ClinConnect ClinConnect Logo
Search / Trial NCT04697823

Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate.

Launched by KU LEUVEN · Jan 5, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether using a special medium enriched with hyaluronan can help improve the chances of becoming pregnant after fertility treatments. The researchers want to see if this medium can increase the overall pregnancy rates for women who are undergoing oocyte retrieval, which is a procedure to collect eggs for fertilization.

To participate in this study, women need to be under 40 years old and have previously tried to get pregnant with their own eggs without success. They should also have a body mass index (BMI) of 32 or lower. Participants will be closely monitored throughout the trial to see how well the hyaluronan-enriched medium works for them. It's important for anyone interested to give their written consent to join the study.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients with own oocytes/embryos;
  • Patients with female age at 1st OR in the study \<40 year;
  • Patients planned for a 2nd oocyte retrieval, with no clinical ongoing pregnancy after the previous oocyte retrieval
  • Patients planned for a 3rd oocyte retrieval with no clinical ongoing pregnancy after previous oocyte retrievals
  • Patients with female age at 1st OR in the study \<40 year;
  • Patients with BMI ≤32;
  • Patients with written informed consent;
  • Exclusion Criteria:
  • -

About Ku Leuven

KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.

Locations

Leuven, , Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials